
Neogen Corp
NASDAQ:NEOG

Neogen Corp?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.39
17.58
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Neogen Corp hold over its rivals?
What risks and challenges
does Neogen Corp face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Neogen Corp.
Provide an overview of the primary business activities
of Neogen Corp.
What unique competitive advantages
does Neogen Corp hold over its rivals?
What risks and challenges
does Neogen Corp face in the near future?
Has there been any significant insider trading activity
in Neogen Corp recently?
Summarize the latest earnings call
of Neogen Corp.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Neogen Corp.
Provide P/S
for Neogen Corp.
Provide P/E
for Neogen Corp.
Provide P/OCF
for Neogen Corp.
Provide P/FCFE
for Neogen Corp.
Provide P/B
for Neogen Corp.
Provide EV/S
for Neogen Corp.
Provide EV/GP
for Neogen Corp.
Provide EV/EBITDA
for Neogen Corp.
Provide EV/EBIT
for Neogen Corp.
Provide EV/OCF
for Neogen Corp.
Provide EV/FCFF
for Neogen Corp.
Provide EV/IC
for Neogen Corp.
Show me price targets
for Neogen Corp made by professional analysts.
What are the Revenue projections
for Neogen Corp?
How accurate were the past Revenue estimates
for Neogen Corp?
What are the Net Income projections
for Neogen Corp?
How accurate were the past Net Income estimates
for Neogen Corp?
What are the EPS projections
for Neogen Corp?
How accurate were the past EPS estimates
for Neogen Corp?
What are the EBIT projections
for Neogen Corp?
How accurate were the past EBIT estimates
for Neogen Corp?
Compare the revenue forecasts
for Neogen Corp with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Neogen Corp and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Neogen Corp against its competitors.
Analyze the profit margins
(gross, operating, and net) of Neogen Corp compared to its peers.
Compare the P/E ratios
of Neogen Corp against its peers.
Discuss the investment returns and shareholder value creation
comparing Neogen Corp with its peers.
Analyze the financial leverage
of Neogen Corp compared to its main competitors.
Show all profitability ratios
for Neogen Corp.
Provide ROE
for Neogen Corp.
Provide ROA
for Neogen Corp.
Provide ROIC
for Neogen Corp.
Provide ROCE
for Neogen Corp.
Provide Gross Margin
for Neogen Corp.
Provide Operating Margin
for Neogen Corp.
Provide Net Margin
for Neogen Corp.
Provide FCF Margin
for Neogen Corp.
Show all solvency ratios
for Neogen Corp.
Provide D/E Ratio
for Neogen Corp.
Provide D/A Ratio
for Neogen Corp.
Provide Interest Coverage Ratio
for Neogen Corp.
Provide Altman Z-Score Ratio
for Neogen Corp.
Provide Quick Ratio
for Neogen Corp.
Provide Current Ratio
for Neogen Corp.
Provide Cash Ratio
for Neogen Corp.
What is the historical Revenue growth
over the last 5 years for Neogen Corp?
What is the historical Net Income growth
over the last 5 years for Neogen Corp?
What is the current Free Cash Flow
of Neogen Corp?
Discuss the annual earnings per share (EPS)
trend over the past five years for Neogen Corp.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Neogen Corp
NASDAQ:NEOG
|
1.1B USD | 13 | |
CH |
![]() |
Alcon AG
SIX:ALC
|
36B CHF | 18.6 |
|
JP |
![]() |
Hoya Corp
TSE:7741
|
6.4T JPY | 19.5 |
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
138.3B DKK | 17.6 |
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
14.9B USD | 17.5 |
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
5.8B CHF | 31.6 |
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
5B GBP | 208.1 |
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.6B CNY | 26.3 |
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.1B USD | 9.2 |
|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
5B USD | 17.2 |
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
5B USD | 19.1 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Neogen Corp
NASDAQ:NEOG
|
Average EV/EBITDA:
36.2
13
|
3%
|
4.3 | |
CH |
![]() |
Alcon AG
SIX:ALC
|
18.6
|
10%
|
1.9 |
|
JP |
![]() |
Hoya Corp
TSE:7741
|
19.5
|
9%
|
2.2 |
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
17.6
|
9%
|
2 |
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
17.5
|
15%
|
1.2 |
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
31.6
|
N/A | N/A |
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
208.1
|
11%
|
18.9 |
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
26.3
|
18%
|
1.5 |
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
9.2
|
21%
|
0.4 |
|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
17.2
|
19%
|
0.9 |
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
19.1
|
12%
|
1.6 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.